================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (Date of earliest event reported): DECEMBER 31, 1996
LIFECELL CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 0-19890 76-0172936
(State of Incorporation) (Commission File No.) (I.R.S. Employer
Identification No.)
3606 RESEARCH FOREST DRIVE
THE WOODLANDS, TEXAS 77381
(Address of Principal Executive Offices) (Zip Code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (281) 367-5368
================================================================================
<PAGE>
ITEM 5. OTHER EVENTS
At the request of The Nasdaq Stock Market, LifeCell Corporation (the
"Company") is filing this Current Report on Form 8-K which includes its balance
sheet as of November 30, 1995 to evidence the Company's compliance with The
Nasdaq Stock Market's continuing listing requirements for SmallCap issuers.
EXHIBIT A: LifeCell Corporation Balance Sheet as of November 30, 1996.
Page 2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LIFECELL CORPORATION
Dated: December 31, 1996 By: /s/ PAUL M. FRISON
Paul M. Frison
President and Chief Executive Officer
Page 3
<PAGE>
EXHIBIT A
LIFECELL CORPORATION
Balance Sheet
November 30, 1996
(Unaudited)
Assets
Cash and cash equivalents $11,039,707.73
Accounts receivable, net 432,705.18
Inventories 774,020.22
Prepayment and other 62,843.87
----------------
Total Current Assets 12,309,277.00
Furniture and equipment, net 444,453.88
Intangible assets, net 324,258.94
----------------
Total Assets $13,077,989.82
Liabilities
Accounts payable $264,608.66
Notes payable 18,761.11
Accrued liabilities 393,839.82
Deferred revenues 1,682,902.12
---------------
Total Liabilities 2,360,111.71
===============
Stockholders' Equity
Series A preferred stock 5,663,349.98
Series B preferred stock 124.16
Common stock 4,778.89
Warrants 423,218.00
Paid-in capital 33,251,598.84
Accumulated deficit (25,072,129.43)
Current year deficit (3,553,062.33)
---------------
Total Stockholders' Equity 10,717,878.11
----------------
Total Liabilities and Stockholders' Equity $13,077,989.82
===============